Home NDC 25021-332-84 Norepinephrine Bitartrate in Dextrose
Product NDC 25021-332
Requested package NDC 25021-332-84
11-digit product format 250210332
Labeler code 25021
Product ID 25021-332_df8fbb03-b800-4b63-b4e0-cbfd3e609923
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Norepinephrine Bitartrate
Dosage form INJECTION, SOLUTION
Route INTRAVENOUS
Labeler Sagent Pharmaceuticals
Application ANDA220483
Marketing category ANDA
Marketing start 2026-11-15
Substance NOREPINEPHRINE BITARTRATE
Active strength 64 ug/mL
Pharmacologic classes Catecholamine [EPC], Catecholamines [CS]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A220483-001 NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE NOREPINEPHRINE BITARTRATE EQ 16MG BASE/250ML (EQ 64MCG BASE/ML) SOLUTION / INTRAVENOUS AP 2026-03-26
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A220483-001 AP
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 A220483-001 NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE EQ 16MG BASE/250ML (EQ 64MCG BASE/ML) SOLUTION / INTRAVENOUS AP 2026-03-26 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 A220483-001 NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE EQ 16MG BASE/250ML (EQ 64MCG BASE/ML) SOLUTION / INTRAVENOUS AP 2026-03-26 c2088c7a36db…2026-09-14 22:38:34 2026-08 A220483-001 NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE EQ 16MG BASE/250ML (EQ 64MCG BASE/ML) SOLUTION / INTRAVENOUS AP 2026-03-26 84e616aacf4f…2026-08-18 06:07:40 2026-07 A220483-001 NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE EQ 16MG BASE/250ML (EQ 64MCG BASE/ML) SOLUTION / INTRAVENOUS AP 2026-03-26 caaa826d4ba7…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A220483-001 NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE EQ 16MG BASE/250ML (EQ 64MCG BASE/ML) SOLUTION / INTRAVENOUS AP 2026-03-26 a50c72e98297…
Observed Orange Book normalized TE history# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Norepinephrine Bitartrate in Dextrose
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength NOREPINEPHRINE BITARTRATE 64 ug/mL
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 25021-332-84 25021033284 10 BAG in 1 CARTON (25021-332-84) / 250 mL in 1 BAG 10 bag 2026-11-15 No No Current